Table 4.

Relative Potency of Curcumin Mimics

compd	IC50(curcumin)/IC50(compd)a
	PC-3b		DU145,c WST-1	LNCaP,d WST-1	HeLae
	WST-1	TB			WST-1	TB
curcumin	1	1	1	1	1	1
6	24		29	23	23
7	17		40	17	30
8	37		71	28	53
9	36		48	23	35
10	28		31	12	19
12	82		90	57	64	75
13	37		42	24	34	42
14	36		37	24	30	46
15	42		49	35	37
19	50		58	44	87	51
22	30		27	30	18
24	36		23	23	26	11
26	54		56	59	61	43
30	35		17	20	17
32	54	30	40	33	29	22
36	121	32	77	50	87	24
37	49		63	36	53
38	75		66	26	71
39	64		51	24	61
40	69		38	16	38
41	40		14	12	21
43	111	90	50	30	76	75
44	116	58	61	36	87	95
45	75	53	32	17	53	45
46	85	18	30	19	45	15
47	98	13	32	25	67	11
48	32			15	22	13

^aThe relative potency of curcumin mimics obtained by dividing the IC₅₀ value of curcumin by that of each curcumin mimic.

^bHuman androgen-insensitive prostate cancer cell line.

^cHuman androgen-insensitive prostate cancer cell line.

^dHuman androgen-sensitive prostate cancer cell line.

^eHuman aggressive cervical cancer cell line.